Undisclosed in vivo CD19/CD20 bispecific CAR-T
/ Fosun Kairos
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
An in vivo CD19/CD20 bispecific CAR-T cell product with engineered lentivirus and optimized T-cell targets
(SITC 2026)
- No abstract available
Bispecific • CAR T-Cell Therapy • Preclinical • Oncology • CD20
1 to 1
Of
1
Go to page
1